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Blood pressure (BP) follows a circadian rhythm with a 10–15% 
fall at night. Subjects who fail to show a 10% nocturnal BP 
decrease are considered to be “nondippers.”1 BP nondipping 
is associated with target organ damage and cardio vascular 
mortality.2–4 Ambulatory BP might better predict mortal-
ity than casual BP readings.5 Also, night-time ambulatory BP 
might be a better predictor of mortality than daytime BP and 
the night–day ambulatory BP ratio appears to predict all-cause 
mortality, independently of 24-h BP.5,6 Although several neu-
rohormonal systems regulating BP have been shown to follow 
a circadian rhythm and may contribute to the abnormal cir-
cadian variations in BP observed in some subjects, the exact 
causes of the nondipping pattern have not been well identi-
fied yet. Determinants of the circadian BP variations seem to 
include variations in the activity of the sympathetic nervous 
system7,8 and the capacity to excrete sodium during daytime.9
The white-coat effect is usually defined as the difference 
between office BP and either daytime ambulatory BP or home 
BP. This effect can be observed in normotensive as well as in 
hypertensive subjects. White-coat hypertension (WCH), also 
called isolated office hypertension, refers to a persistently ele-
vated BP in the office together with a normal BP outside of the 
office. WCH is generally defined as office BP ≥140/90 mm Hg 
with daytime ambulatory BP <135/85 mm Hg. WCH can be 
found in 10–18% of the general population10,11 and in 10–38% 
of hypertensive subjects.11,12
It is generally recognized that patients with WCH have a 
lower risk of target organ damages and cardiovascular compli-
cations than truly hypertensive patients.13 Yet, they appear to 
have more target organ damage than normotensive subjects. In 
cross-sectional studies, WCH has been associated with carotid 
atherosclerosis,14 impaired arterial distensibility,15 higher left-
ventricular mass,14 greater proteinuria, and left-ventricular 
diastolic dysfunction.15 However, a significant difference in 
target organ damage between white-coat hypertensive and nor-
motensive subjects was not found in other studies.16,17 In longi-
tudinal studies, WCH was found to be a risk factor for  sustained 
hypertension,18 insulin resistance,19 and increased all-cause 
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Background
In this study, we assessed whether the white-coat effect (difference 
between office and daytime blood pressure (bP)) is associated with 
nondipping (absence of bP decrease at night).
Methods
Data were available in 371 individuals of African descent from 74 
families selected from a population-based hypertension register in 
the Seychelles Islands and in 295 caucasian individuals randomly 
selected from a population-based study in Switzerland. We used 
standard multiple linear regression in the Swiss data and generalized 
estimating equations to account for familial correlations in the 
Seychelles data.
results
the prevalence of systolic and diastolic nondipping (<10% 
nocturnal bP decrease) and white-coat hypertension (WcH) was 
respectively 51, 46, and 4% in blacks and 33, 37, and 7% in whites. 
When white-coat effect and nocturnal dipping were taken as 
continuous variables (mm Hg), systolic (SbP) and diastolic bP 
(DbP) dipping were associated inversely and independently with 
white-coat effect (P < 0.05) in both populations. Analogously, the 
difference between office and daytime heart rate was inversely 
associated with the difference between daytime and night-time 
heart rate in the two populations. these results did not change  
after adjustment for potential confounders.
conclusions
the white-coat effect is associated with bP nondipping. the similar 
associations between office–daytime values and daytime–night-
time values for both bP and heart rate suggest that the sympathetic 
nervous system might play a role. our findings also further stress the 
interest, for clinicians, of assessing the presence of a white-coat effect 
as a means to further identify patients at increased cardiovascular risk 
and guide treatment accordingly.
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mortality.20 The association of WCH with cardiovascular 
 outcomes was not confirmed in other longitudinal studies.21,22 
The mechanisms of the pressor response in patients with WCH 
are not well understood. Psychological as well as behavio-
ral factors linked to the stress of the medical consultation and 
to anxiety have been identified in these patients. These factors 
may activate the sympathetic  nervous system and increase BP 
responsiveness to the medical environment.
We hypothesized that the white-coat effect and BP nondip-
ping could share common pathophysiological mechanisms, 
i.e., an overactivity of the sympathetic nervous system. The 
possibility of an association between these two phenomena 
was once tested by Palatini et al. in 1,013 hypertensive patients, 
but no significant association was found.23 In this study, we 
analyzed whether (i) the white-coat effect was associated with 
BP dipping on a continuous scale, (ii) similar associations, if 
any, could be found for heart rate, and (iii) WCH was asso-
ciated with BP nondipping, in 371 black normotensive and 
hypertensive individuals in the Seychelles as well as in 295 
white s ubjects enrolled recently in an ongoing population-
based study in Switzerland.
Methods
Seychelles. The study took place in the Seychelles islands, 
where the population is of predominantly African descent. The 
study was approved by the Ethical Committees of the Ministry 
of Health in the Seychelles and the University of Lausanne 
(Switzerland). All participants provided written informed con-
sent. The selection criteria for the study have been described 
elsewhere.24 In brief, participants were recruited between August 
1999 and January 2002 along a family-based approach. Based on 
BP information of an ongoing national hypertension register 
that includes all patients with hypertension who attend primary 
health care centers, families with two or more first-degree mem-
bers included in the register were identified. Of the 135 screened 
families 76 were found to be eligible. A total of 371 subjects from 
74 families had data available for the present analyses.
Antihypertensive therapy, if any, was stopped for 2 weeks 
before performing ambulatory BP monitoring. Two sets of 
triplicate office BP measurements (one on the day before and 
one on the day after ambulatory BP monitoring) were taken in 
the morning between 7.00 and 10.30 am by trained health pro-
fessionals on subjects who had been sitting quietly for at least 
10 min, using a standard mercury sphygmomanometer with a 
triple-bladder cuff (Tricuff) that automatically adjusts bladder 
width to arm circumference. Ambulatory BP was monitored 
using validated25 electronic Diasys devices (DIASYS Integra; 
Novacor, Rueil-Malmaison, France) placed on the left arm with 
an appropriately sized cuff. Measurements were recorded every 
20 min during the day and every 30 min during the night. The 
actual awake and asleep periods were used, as reported by par-
ticipants, to define daytime and night time. Validation criteria 
have been previously described.26 For the analyses, the aver-
age of 10 randomly selected daytime and 10 randomly selected 
night-time BP measures was used to have the same number 
of measures for each participant and for each  period.26 The 
white-coat effect was defined as office minus daytime ambula-
tory BP, for systolic BP (SBP), diastolic BP (DBP), and heart 
rate. WCH was defined as office BP ≥140/90 mm Hg with day-
time ambulatory BP <135/85 mm Hg (ref. 1). Dipping was 
defined as daytime minus night-time  values for ambulatory BP 
or heart rate. Nondipping was defined as a <10% proportional 
nocturnal decrease for SBP, DBP, or heart rate.
Urinary and plasma sodium and potassium concentrations 
were measured by flame photometry (IL-943; Instrumentation 
Laboratory, Milan, Italy) and creatinine concentration was 
measured by the picric acid method (Cobas-Mira; Roche, 
Basel, Switzerland). Glomerular filtration rate was estimated 
using the abbreviated Modification of the Diet in Renal Disease 
(MDRD) equation 27.
Switzerland. We randomly selected participants to the CoLaus 
study,28 who were a representative sample of the Caucasian 
population aged 35–75 years in 2003–2006 in the city of 
Lausanne, Switzerland. The study is ongoing and so far 295 
had data available for the present analyses. We used the same 
method (device and criteria) to measure ambulatory BP and 
24-h urine collection as in the Seychelles, and the same defini-
tions for dipping and white-coat effect. In Switzerland, antihy-
pertensive treatment was not stopped before conducting the 
ambulatory BP monitoring. Office BP was measured using a 
validated automatic oscillometric BP device (Omron HEM 
907; Omron Healthcare Europe, Hoofddorp, the Netherlands). 
Office BP was defined by the mean of three measurements per-
formed by the same research assistant just before the ambula-
tory BP device was installed.
Statistical analyses. We used Stata 10.0 (StataCorp, College 
Station, TX) to conduct all statistical analyses. Continuous vari-
ables were compared with t-tests and categorical variables with 
χ2-tests. Spearman rank correlation coefficients were used to 
measure association between white-coat effect and dipping for 
SBP, DBP, and heart rate. We assessed trends across tertiles of 
white-coat effect, separately for SBP, DBP, and heart rate, using 
a nonparametric test for trend. We used generalized estimat-
ing equations with an exchangeable correlation structure and a 
Gaussian link for continuous dependent variables or a logit link 
for dichotomous dependent variables to account for the familial 
correlations in the Seychelles data. In the Swiss data, we used 
standard multiple linear or logistic regressions because partici-
pants were unrelated. Continuous dipping (mm Hg) was used 
as the dependent variable and continuous white-coat effect 
(mm Hg) as the predictor of interest, using separate models 
for SBP, DBP, and heart rate. Different sets of covariate adjust-
ments were compared to assess the effect of potential con-
founders. We conducted sensitivity analyses that (i) excluded 
participants taking antihypertensive treatment in Switzerland 
and in Seychelles; (ii) added a correction for ascertainment 
in Seychelles as previously described24 (correction for ascer-
tainment aims to determine what would have been the results 
had the investigators not ascertained this way). We corrected 
the models for BP ascertainment by including as a  covariate 
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an indicator variable whose value was 1 if the  participant was 
hypertensive and whose value was 0 otherwise.
results
In Seychelles, the study included 167 men and 204 women 
from 74 pedigrees, each with at least two hypertensive siblings. 
Overall there were 176 normotensive and 195 hypertensive 
participants. Women were slightly older (mean ± s.d.: 47.5 ± 
12.5 vs. 45.5 ± 11.2 years) and more overweight (28.7 ± 5.1 vs. 
26.1 ± 4.6) than men. The 24-h urinary sodium and potassium 
excretions were 109 and 49 mmol/24-h, respectively. The 24-h 
urinary creatinine excretions were 0.17 mmol/kg in women 
and 0.21 mmol/kg in men. The prevalence of nondipping was 
51% (190/371) for SBP, 46% for DBP, and 12% (45/371) for 
heart rate. The prevalence of WCH was 4% (15/371).
In Switzerland, the study included 143 men and 152 women, 
with mean ± s.d. age 56.1 ± 9.8 and 57.2 ± 10.5 years (P = 0.36), 
and mean body mass index 26.8 ± 3.4 and 24.6 ± 4.0 kg/m2 (P < 
0.001), respectively. The prevalence of hypertension, defined 
as office BP ≥140/90 mm Hg or being on  antihypertensive 
 treatment, was 29% in men and 26% in women, of which 55 
and 50% were treated, respectively. By comparison, the preva-
lence of hypertension in the entire CoLaus study was signifi-
cantly higher in men (43%, P < 0.05), but similar in women 
(31%, P = 0.42). The 24-h urinary sodium and potassium 
excretions were 134 and 64 mmol/24-h, respectively. The 24-h 
 urinary  creatinine excretions were 0.15 mmol/kg in women and 
0.19 mmol/kg in men. The prevalence of nondipping was 33% 
(97/295) for SBP, 37% (109/295) for DBP, and 20% (60/295) for 
heart rate. The prevalence of WCH was 7% (22/295).
In Seychelles (Figure 1a), the distributions of the SBP/DBP 
dippings were centered at 13.3/9.0 mm Hg and those of the 
systolic/diastolic white-coat effects at 1.7/0 mm Hg, respectively. 
In Switzerland (Figure 1b), the distributions of the SBP/DBP 
dippings were centered at 16/10 mm Hg and those of the systo-
lic/diastolic white-coat effects at 4.1/−7.3 mm Hg, respectively.
Both in absolute (i.e., in mm Hg) and relative (i.e.,  proportional 
dipping) terms, SBP dipping was substantially lower in subjects 
within the highest tertile of SBP white-coat effect as calculated 
by the office–ambulatory daytime SBP difference and this for 
table 1 | Blood pressure and heart rate by tertiles of systolic, diastolic, and heart rate white-coat effects, seychelles
All
White-coat effect
P trendTertile 1 Tertile 2 Tertile 3
Systolic blood pressure, N 371 124 124 123
 Age (years) 46.6 ± 0.6 42.1 ± 1.0 47.3 ± 1.1 50.4 ± 1.0 <0.001
 body mass index (kg/m2) 27.0 ± 0.3 26.2 ± 0.4 27.3 ± 0.4 27.5 ± 0.5 0.03
 MDrD (ml/min/1.73 m2) 115 ± 3 118 ± 6 110 ± 3 115 ± 8 0.21
 White-coat effect (mm Hg) 1.6 ± 0.7 −11.9 ± 0.7 1.7 ± 0.3 15.2 ± 0.7 <0.001
 office (mm Hg) 132.8 ± 1.0 122.0 ± 1.5 133.3 ± 1.6 143.3 ± 1.6 <0.001
 Daytime (mm Hg) 131.2 ± 0.9 133.9 ± 1.7 131.5 ± 1.6 128.1 ± 1.4 0.039
 Night time (mm Hg) 117.9 ± 0.9 116.3 ± 1.5 119.3 ± 1.6 118.1 ± 1.4 0.230
 Absolute dipping (mm Hg) 13.3 ± 0.5 17.6 ± 0.8 12.2 ± 0.9 10.0 ± 0.8 <0.001
 Proportional dipping (proportion) 0.10 ± 0.00 0.13 ± 0.01 0.09 ± 0.01 0.08 ± 0.01 <0.001
Diastolic blood pressure, N 371 124 124 123
 White-coat effect (mm Hg) 0.0 ± 0.4 −8.6 ± 0.4 0.3 ± 0.2 8.3 ± 0.4 <0.001
 office (mm Hg) 84.9 ± 0.6 80.0 ± 1.0 83.9 ± 0.9 90.8 ± 1.0 <0.001
 Daytime (mm Hg) 84.9 ± 0.6 88.6 ± 1.1 83.6 ± 0.9 82.5 ± 1.0 <0.001
 Night time (mm Hg) 75.9 ± 0.6 76.7 ± 1.2 75.1 ± 1.0 76.0 ± 1.0 0.967
 Absolute dipping (mm Hg) 9.0 ± 0.4 11.9 ± 0.6 8.5 ± 0.6 6.6 ± 0.5 <0.001
 Proportional dipping (proportion) 0.11 ± 0.00 0.14 ± 0.01 0.10 ± 0.01 0.08 ± 0.01 <0.001
Heart rate, N 371 125 123 123
 White-coat effect (beats/min) −4.1 ± 0.4 −12.6 ± 0.4 −3.9 ± 0.2 4.5 ± 0.4 <0.001
 office (beats/min) 74.9 ± 0.5 71.1 ± 0.8 74.2 ± 0.9 79.4 ± 0.9 <0.001
 Daytime (beats/min) 78.9 ± 0.5 83.7 ± 0.9 78.1 ± 0.9 75.0 ± 0.8 <0.001
 Night time (beats/min) 64.0 ± 0.4 64.7 ± 0.7 63.9 ± 0.8 63.2 ± 0.7 0.172
 Absolute dipping (beats/min) 15.0 ± 0.4 19.0 ± 0.6 14.1 ± 0.6 11.8 ± 0.5 <0.001
 Proportional dipping (proportion) 0.19 ± 0.00 0.22 ± 0.01 0.18 ± 0.01 0.16 ± 0.01 <0.001
Data are means ± s.e. Tertiles are sex-specific, and therefore have the same proportion of men and women. The tertiles for systolic, diastolic and pulse data do not encompass the 
same subjects. White-coat effect is calculated as office minus daytime ambulatory values. Dipping is calculated as daytime minus night-time ambulatory values. P values are for a 
nonparametric test for trend across tertiles.
MDRD, Modification of the Diet in Renal Disease
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both populations (Tables 1 and 2). The same observation was 
made when subjects were classified into tertiles of DBP or heart 
rate white-coat effects.
Taken as a categorical variable, WCH was a significant 
determinant of both SBP nondipping (odds ratio ± s.e. = 4.0 ± 
2.6, P = 0.03) and DBP nondipping (odds ratio = 5.0 ± 3.3, P = 
0.01) in the Seychelles. These associations were similar after 
adjustment for potential confounding factors such as age, sex, 
body mass index, and daytime SBP. In Switzerland, the associ-
ations of WCH with SBP nondipping (odds ratio ± s.e. = 2.1 ± 
1.0, P = 0.11) and DBP nondipping (odds ratio =1.6 ± 0.7, P = 
0.30) were also positive, but not significant.
Taken as a continuous variable, the SBP white-coat effect 
was significantly and inversely correlated with the SBP dip-
ping (P < 0.001) in the Seychelles as well as in Switzerland (P < 
0.001) (Figure 2), suggesting that a large SBP white-coat effect 
is associated with reduced SBP dipping. Similar observations 
were made for DBP and heart rate.
Mean white-coat effects by selected categories of dipping 
are presented in Figure 3. In both populations, the larger SBP 
white-coat effect observed in SBP nondippers was  independent 
of daytime SBP. The nonsignificant difference in tertile 2 in 
Switzerland may reflect low power due to a small number 
of nondippers in this group. Moreover, similar results were 
obtained in normotensive and hypertensive subjects (data not 
shown). For DBP and heart rate, results were analogous but 
less significant (data not shown).
The results of multiple linear regressions are presented in 
Table 3. In both populations, the SBP white-coat effect was sig-
nificantly and inversely associated with the SBP  dipping, even 
after adjusting for possible confounding factors. Our results 
indicate that, at equal daytime SBP, the higher the  systolic 
white-coat effect, the smaller the SBP dipping, or in other 
words, the higher the night-time SBP. Similar results were 
obtained for DBP and for heart rate.
We also conducted additional analyses using night-time BP 
as the dependent variable and office and daytime BP as inde-
pendent variables of interest, to avoid the simultaneous use of 
daytime BP in both sides of the equation (i.e., dependent and 
independent variables), As shown in Table 4, after adjustment 
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for age, sex, body mass index, antihypertensive treatment, uri-
nary sodium and potassium excretion, for a given daytime BP 
and heart rate, night-time BP was higher when office BP meas-
ured in the morning was higher confirming that the greater 
the white-coat effect the smaller the dipping at night. This was 
true for both populations, for SBP as well for DBP and heart 
rate. Sensitivity analyses provided very similar results (i.e., that 
differed by <1 standard error from the main analyses) and did 
not change our conclusions.
discussion
We found an inverse association between the white-coat 
effect—as assessed by the difference between several office BP 
readings and ambulatory daytime BP—and BP dipping—as 
assessed by the difference between daytime and night-time 
ambulatory BP—in two widely different populations. This 
association was independent of daytime BP levels and other 
possible confounding factors. A similar association was also 
found with heart rate (i.e., inverse association between the 
daytime–office difference in heart rate and the daytime–night-
time difference in heart rate). These common associations for 
BP and heart rate are consistent with the hypothesis that the 
white-coat effect and the absence of physiological nocturnal 
BP dipping are mediated by a common pathway, e.g., overac-
tivity of the sympathetic nervous system.
The basis of our hypothesis was supported by several previ-
ous observations. The white-coat effect was initially described 
as a defense reaction against the person measuring BP, which 
included an increase in both BP and heart rate, and was believed 
to be an alert reaction mediated essentially by the sympathetic 
nervous system.29 Although this description was done >20 years 
ago, there has been little evidence to either support or refute 
this hypothesis. Nonetheless, WCH has been  associated with 
increased muscle sympathetic nerve  activity when  compared 
to normotension.30 Moreover, additional  indirect evidence for 
sympathetic overactivity is supported by the findings that the 
table 2 | Blood pressure and heart rate by tertiles of systolic, diastolic, and heart rate white-coat effect, switzerland
All
White-coat effect
P trendTertile 1 Tertile 2 Tertile 3
Systolic blood pressure, N 295 99 99 97
 Age (years) 56.6 ± 0.6 53.7 ± 1.0 56.7 ± 1.0 59.5 ± 1.0 <0.001
 body mass index (kg/m2) 25.7 ± 0.2 25.0 ± 0.4 25.6 ± 0.4 26.5 ± 0.4 0.01
 MDrD (ml/min/1.73 m2) 80 ± 1 81 ± 1 79 ± 2 80 ± 2 0.48
 White-coat effect (mm Hg) 4.1 ± 0.8 −9.2 ± 0.7 4.2 ± 0.3 17.6 ± 1 <0.001
 office (mm Hg) 125.8 ± 1 116.9 ± 1.3 123.7 ± 1.4 137 ± 1.8 <0.001
 Daytime (mm Hg) 121.7 ± 0.9 126.1 ± 1.5 119.5 ± 1.3 119.4 ± 1.5 0.0028
 Night time (mm Hg) 105.7 ± 0.9 106.7 ± 1.5 102.6 ± 1.4 107.8 ± 1.6 0.7842
 Absolute dipping (mm Hg) 16 ± 0.7 19.5 ± 1.1 16.9 ± 1 11.7 ± 1.2 <0.001
 Proportional dipping  
 (proportion)
0.13 ± 0.01 0.15 ± 0.01 0.14 ± 0.01 0.10 ± 0.01 <0.001
Diastolic blood pressure, N 295 99 99 97
 White-coat effect (mm Hg) −7.3 ± 0.5 −16.7 ± 0.5 −7.7 ± 0.3 2.7 ± 0.6 <0.001
 office (mm Hg) 71.9 ± 0.6 66 ± 0.9 69.7 ± 0.8 80.2 ± 1 <0.001
 Daytime (mm Hg) 79.2 ± 0.5 82.7 ± 1 77.4 ± 0.8 77.5 ± 0.9 0.0001
 Night time (mm Hg) 68.9 ± 0.5 70 ± 0.8 67.4 ± 0.8 69.2 ± 0.9 0.4774
 Absolute dipping (mm Hg) 10.3 ± 0.4 12.7 ± 0.7 10 ± 0.7 8.2 ± 0.6 <0.001
 Proportional dipping  
 (proportion)
0.13 ± 0.01 0.15 ± 0.01 0.13 ± 0.01 0.10 ± 0.01 0.0001
Heart rate, N 295 99 100 96
 White-coat effect (beats/min) −9.1 ± 0.5 −18.3 ± 0.5 −8.2 ± 0.2 −0.6 ± 0.5 <0.001
 office (beats/min) 70.6 ± 0.6 65.4 ± 1 70.9 ± 0.9 75.7 ± 1.1 <0.001
 Daytime (beats/min) 79.8 ± 0.6 83.7 ± 1 79.1 ± 0.9 76.4 ± 0.9 <0.001
 Night time (beats/min) 64.9 ± 0.5 64 ± 0.9 65.4 ± 0.9 65.2 ± 0.8 0.4332
 Absolute dipping (beats/min) 14.9 ± 0.5 19.7 ± 0.9 13.7 ± 0.7 11.2 ± 0.7 <0.001
 Proportional dipping  
 (proportion)
0.18 ± 0.01 0.23 ± 0.01 0.17 ± 0.01 0.14 ± 0.01 <0.001
Data are means ± s.e. Tertiles are sex-specific, and therefore have the same proportion of men and women. The tertiles for systolic, diastolic and pulse data do not encompass the 
same subjects. White-coat effect is calculated as office minus daytime ambulatory values. Dipping is calculated as daytime minus night-time ambulatory values. P values are for a 
nonparametric test for trend across tertiles.
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white-coat effect is associated with increased BP reactivity to 
(i) stress,31,32 although this was not confirmed in all studies,33 
(ii) standing,32,34 or (iii) anxiety.35
There is also substantial experimental evidence that the 
sympathetic activity contributes to the circadian rhythm of 
BP. In rats, sympathectomy abolishes the circadian rhythm 
of BP.36,37 Dopamine β-hydroxylase knockout mice, which 
completely lack epinephrine and norepinephrine, have an 
attenuated circadian rhythm of BP.38 Few data exist in humans 
probably because of the difficulty to measure the sympa-
thetic activity overnight. However, nondippers, in particular 
African Americans, tend to have smaller daytime–night-time 
difference in urinary excretion of catecholamines and higher 
α1-adrenergic responsiveness than dippers.7 Palatini et al.23 
did not find a statistically significant association between 
white-coat effect and BP dipping in hypertensive patients, 
but the trend observed in their study was consistent with our 
findings. In a recent study, patients with WCH and increased 
number of metabolic syndrome components had higher night-
time SBP levels.39 As the metabolic syndrome is associated 
with sympathetic overactivity, this latter observation is also 
consistent with our hypothesis.
One potential limitation in our study is that daytime SBP 
is included in both sides of the equation (i.e., dependent and 
independent variables). Therefore, we performed additional 
statistical analysis in which daytime SBP was used only as inde-
pendent variable (see Table 4). In these analyses, for a given 
daytime BP, night-time BP was positively associated with office 
BP. These analyses confirmed that, for any given daytime BP, 
high white-coat effect is associated with reduced dipping pat-
tern. Another limitation relates to the fact that the Seychelles 
study included families enriched in  hypertensive individuals, 
which may limit the external validity of our  findings. However, 
similar results were obtained in all BP  tertiles in the Seychelles 
(the lowest including mostly normotensive persons) as well as 
in unrelated subjects from the general population of a Swiss 
city. Dietary salt intake was low in both study populations and 
our results may therefore not apply to other groups with higher 
table 3 | associations between the white-coat effecta and dipping for blood pressureb and heart rate, based on multiple 
linear regression
Country Dependent variable Covariates
Coefficient (s.e.) (mm Hg dipping/ 
10 mm Hg white-coat effect) P value
Seychelles SbP dipping (mm Hg) None −2.70 (0.38) <0.001
Full modelc −1.86 (0.40) <0.001
DbP white-coat effect (mm Hg) None −3.41 (0.41) <0.001
Full modelc −2.45 (0.43) <0.001
Heart rate white-coat effect (beats/min) None −4.30 (0.42) <0.001
Full modelc −2.51 (0.40) <0.001
Switzerland SbP dipping (mm Hg) None −2.90 (0.49) <0.001
Full modelc −1.40 (0.55) 0.011
DbP white-coat effect (mm Hg) None −1.99 (0.43) <0.001
Full modelc −1.22 (0.44) 0.006
Heart rate white-coat effect (beats/min) None −4.22 (0.53) <0.001
Full modelc −2.71 (0.55) <0.001
In Seychelles, models were also adjusted for persons who measured office BP and for being taken off antihypertensive treatment. In Switzerland, models were also adjusted for being 
on current antihypertensive treatment.
DBP, diastolic blood pressure; SBP, systolic blood pressure.
aWhite-coat effect is calculated as office minus daytime ambulatory values. bDipping is calculated as daytime minus night-time ambulatory values. cFull models are adjusted for age, sex, 
body mass index, daytime SBP (or DBP or heart rate), urinary sodium excretion, and urinary potassium excretion.
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Figure 3 | Proportional white-coat effect vs. dipping status of (a) Seychelles 
and (b) Switzerland, by tertiles of daytime ambulatory systolic blood pressure. 
Dippers were defined as subjects having at least 10% nocturnal systolic 
blood pressure decrease. All the other subjects were classified as nondippers. 
P values are from t-tests comparing white-coat effect (i.e., office-day bP 
difference) by dipping status.
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dietary salt intakes. As previously discussed,24 even in partici-
pants with urinary creatinine excretion above the sex-specific 
20th percentile (0.154 mmol/kg/24 h for men and 0.112 mmol/
kg/24 h for women), urinary sodium excretion was as low as 
114 mmol/24 h. We consider that these results reflect low die-
tary salt intake in Seychelles. The urinary sodium excretion 
obtained in the Swiss sample is in line with previous reports.40
Does the observed inverse association between the white-
coat effect and the nocturnal dipping pattern have any clinical 
implication for physicians? Night-time BP is still not measured 
on a regular basis by physicians, although it might represent 
a better predictor of cardiovascular risk and mortality than 
daytime BP.5,6 By contrast, it is easier to identify a white-coat 
effect or WCH with home BP measurements. A message for 
physicians is that when they identify patients with white-coat 
effect, these patients may also present a nondipping BP at 
night time. Subsequently, these patients might be at higher risk 
of developing target organ damage. Further studies are needed 
to determine whether specific interventions on night-time BP 
can improve the prognosis of these patients.
Perspectives
We found that the white-coat effect occurring in the physician’s 
office is associated with reduced nocturnal BP dipping in two 
genetically and environmentally different populations. The 
 similar associations between office–ambulatory and daytime– 
night-time differences observed for both BP and heart rate 
 suggest similar underlying mechanisms, which may be medi-
ated by the sympathetic nervous system. Considering the high 
disease burden of hypertension and, in particular, the potential 
impact of nocturnal hypertension,6 our findings also  further 
stress the interest, for clinicians, of assessing the presence of 
a white-coat effect as a means to further identify patients at 
increased cardio vascular risk and guide treatment accordingly.
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